Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arjan van de Loosdrecht

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Best Practice & Research. Clinical Haematology|February 11, 2014
Erythropoiesis stimulating agents and other growth factors in low-risk MDSEva Hellström-Lindberg, Arjan van de Loosdrecht
Best Practice & Research. Clinical Haematology|June 18, 2019
Can we incorporate MRD assessment into clinical practice in AML?Gert Ossenkoppele, Gerrit Jan Schuurhuis, Arjan van de Loosdrecht, et al.
Leukemia Research|June 20, 2007
Flow cytometry in myelodysplastic syndromes: report from a working conferenceMichael R Loken, Arjan van de Loosdrecht, Kiyoyuki Ogata, et al.
European Journal of Haematology|June 26, 2022
Management of infection prophylaxis in Dutch patients with myelodysplastic syndromes, a web-based case vignette questionnaire: The MINDSET studyJohanne Rozema, Eric van Roon, Lars Vogelzang, et al.
Leukemia Research|March 20, 2013
Prognosis of acute myeloid leukemia transformed from myelodysplastic syndromes: a multicenter retrospective studyNamiko Okuyama, Wolfgang R Sperr, Katalin Kadar, et al.
Oncoimmunology|June 5, 2013
Priming of PRAME- and WT1-specific CD8<sup>+</sup> T cells in healthy donors but not in AML patients in complete remission: Implications for immunotherapyWillemijn van den Ancker, Jurjen M Ruben, Theresia M Westers, et al.
Hemasphere|November 15, 2019
Diagnosis and Treatment of Chronic Myelomonocytic Leukemias in Adults: Recommendations From the European Hematology Association and the European LeukemiaNetRaphael Itzykson, Pierre Fenaux, David Bowen, et al.
Ejhaem|December 18, 2025
Development of Machine-Assisted, Human-Centred Bone Marrow Cell Classification: Feasibility Analysis in Patients With Myelodysplastic SyndromesKiyoyuki Ogata, Yuto Mochimaru, Leonie Saft, et al.
Leukemia Research|January 30, 2007
Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conferencePeter Valent, Hans-Peter Horny, John M Bennett, et al.
Oncotarget|February 15, 2011
Standards and impact of hematopathology in myelodysplastic syndromes (MDS)Peter Valent, Attilio Orazi, Guntram Büsche, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Best Practice & Research. Clinical Haematology|February 11, 2014
Erythropoiesis stimulating agents and other growth factors in low-risk MDSEva Hellström-Lindberg, Arjan van de Loosdrecht
Best Practice & Research. Clinical Haematology|June 18, 2019
Can we incorporate MRD assessment into clinical practice in AML?Gert Ossenkoppele, Gerrit Jan Schuurhuis, Arjan van de Loosdrecht, et al.
Leukemia Research|June 20, 2007
Flow cytometry in myelodysplastic syndromes: report from a working conferenceMichael R Loken, Arjan van de Loosdrecht, Kiyoyuki Ogata, et al.
European Journal of Haematology|June 26, 2022
Management of infection prophylaxis in Dutch patients with myelodysplastic syndromes, a web-based case vignette questionnaire: The MINDSET studyJohanne Rozema, Eric van Roon, Lars Vogelzang, et al.
Leukemia Research|March 20, 2013
Prognosis of acute myeloid leukemia transformed from myelodysplastic syndromes: a multicenter retrospective studyNamiko Okuyama, Wolfgang R Sperr, Katalin Kadar, et al.
Oncoimmunology|June 5, 2013
Priming of PRAME- and WT1-specific CD8<sup>+</sup> T cells in healthy donors but not in AML patients in complete remission: Implications for immunotherapyWillemijn van den Ancker, Jurjen M Ruben, Theresia M Westers, et al.
Hemasphere|November 15, 2019
Diagnosis and Treatment of Chronic Myelomonocytic Leukemias in Adults: Recommendations From the European Hematology Association and the European LeukemiaNetRaphael Itzykson, Pierre Fenaux, David Bowen, et al.
Ejhaem|December 18, 2025
Development of Machine-Assisted, Human-Centred Bone Marrow Cell Classification: Feasibility Analysis in Patients With Myelodysplastic SyndromesKiyoyuki Ogata, Yuto Mochimaru, Leonie Saft, et al.
Leukemia Research|January 30, 2007
Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conferencePeter Valent, Hans-Peter Horny, John M Bennett, et al.
Oncotarget|February 15, 2011
Standards and impact of hematopathology in myelodysplastic syndromes (MDS)Peter Valent, Attilio Orazi, Guntram Büsche, et al.
Pageof 2